GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artiva Biotherapeutics Inc (NAS:ARTV) » Definitions » Purchase Of Investment

ARTV (Artiva Biotherapeutics) Purchase Of Investment : $-176.15 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Artiva Biotherapeutics Purchase Of Investment?

Artiva Biotherapeutics's purchase of investment for the three months ended in Sep. 2024 was $-142.93 Mil. It means Artiva Biotherapeutics spent $142.93 Mil on purchasing investments. Artiva Biotherapeutics's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2024 was $-176.15 Mil.

Compared with last quarter ($-12.19 Mil in Jun. 2024 ), Artiva Biotherapeutics spent more money on purchasing investments in Sep. 2024 ($-142.93 Mil).


Artiva Biotherapeutics Purchase Of Investment Historical Data

The historical data trend for Artiva Biotherapeutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artiva Biotherapeutics Purchase Of Investment Chart

Artiva Biotherapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
- - - - -49.52

Artiva Biotherapeutics Quarterly Data
Sep20 Dec20 Mar21 Sep21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.31 -14.83 -6.20 -12.19 -142.93

Artiva Biotherapeutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-176.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Artiva Biotherapeutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Artiva Biotherapeutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Artiva Biotherapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
5505 Morehouse Drive, Suite 100, San Diego, CA, USA, 92121
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.